To support these data, serial evaluation of the tumour bioluminescent signals, between days 0 and 18, showed steady increase in the tumour viability in the groups of mice treated with the non‐targeted NT.TPA.TNFαIL2 (Fig 4E). Here, PLAT is linked to neoplasm.